TOKYO, Jun 11 (Pulse News Wire) – CNS CO.,LTD. (4076.T) announced today that its board of directors appointed several candidates for director positions effective August 27, 2026.
The appointments are scheduled to be confirmed during the company's 41st regular shareholders' meeting on August 27, followed by subsequent board meetings. Current directors Seiki Nekko Masahide (President and CEO) and Inoshige Makoto (Director) will continue their roles. Additionally, Kameda Kazuhiro (Director) and external directors Onishi Noriaki and Iwanohara Reiko will also retain their positions. External directors Onishi and Iwanohara are expected to remain independent directors based on Tokyo Stock Exchange criteria. The company has entered into liability limitation agreements with these individuals as mandated by law, setting the compensation limit at the minimum statutory level. Furthermore, CNS CO.,LTD.
Maintains insurance contracts covering potential liabilities arising from the execution of duties by its directors. However, damages resulting from criminal acts or violations of laws recognized by the insured are excluded from coverage. All newly appointed directors will continue to be covered under these insurance policies upon confirmation of their appointments. In addition to these appointments, the company also named Miyakawa Hidehiko, Fukuda Heihachiro, and Horita Takayuki as candidates for audit committee members. They too will undergo similar processes for confirmation and insurance coverage. Former director Tomiyama Hiromi will step down due to term expiration.
🟢 Confidence: High AI-translated content.